There are 2789 resources available
1350P - Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease
Presenter: Amir Sabouhanian
Session: ePoster Display
1352P - A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Presenter: Giulia Mazzaschi
Session: ePoster Display
1359TiP - RELATIVITY-104: First-line relatlimab (RELA) + nivolumab (NIVO) with chemotherapy vs nivo with chemotherapy in stage IV or recurrent non-small cell lung cancer (NSCLC): A phase II, randomized, double-blind study
Presenter: Daniel Morgensztern
Session: ePoster Display
1360TiP - First-line (1L) maintenance therapy with niraparib (nira) + pembrolizumab (pembro) vs placebo + pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L study
Presenter: Suresh Ramalingam
Session: ePoster Display
1435TiP - Adjuvant immunotherapy for resected esophageal squamous cell carcinoma with high risk of recurrence (AIRES): A multicenter, open-label, randomized, controlled phase III trial
Presenter: Xiaozheng Kang
Session: ePoster Display
1436TiP - Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-positive gastric cancer (GC) or gastroesophageal junction (GEJ) adenocarcinoma who have progressed on or after a trastuzumab-containing regimen (DESTINY-gastric04, DG-04): A randomized phase III study
Presenter: Kohei Shitara
Session: ePoster Display
1361TiP - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): A phase (ph) II study (DESTINY-Lung02)
Presenter: Egbert F. Smit
Session: ePoster Display
1598P - Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
Presenter: Maria João de Sousa
Session: ePoster Display
1599P - Vaccination in the COVID-19 era: Attitudes amongst oncology patients
Presenter: Sinead Horan
Session: ePoster Display